Daniel Einhorn
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 1%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Management and Research 28
- Diabetes Treatment and Management 20
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 9
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Metabolism, Diabetes, and Cancer 7
- Co-authors
- Guillermo E. Umpierrez (16 shared papers)George Grunberger (20 shared papers)Irl B. Hirsch (11 shared papers)Yehuda Handelsman (21 shared papers)Alan J. Garber (19 shared papers)Zachary T. Bloomgarden (18 shared papers)Etie S. Moghissi (4 shared papers)Paul S. Jellinger (13 shared papers)
- Journals
- Endocrine Practice (29 papers)Diabetes Care (3 papers)Diabetes Technology & Therapeutics (2 papers)Clinical Therapeutics (1 paper)Frontiers in Endocrinology (1 paper)
- Partner nations
- United StatesAustraliaCzechia
In The Last Decade
Daniel Einhorn
42 papers receiving 7.2k citations
Daniel Einhorn's Hit Papers
Peers
Comparison fields: 5 of 134
- Endocrinology, Diabetes and Metabolism 5.0k
- Pharmacology 565
- Physiology 782
- Surgery 1.2k
- Cardiology and Cardiovascular Medicine 473
Countries citing papers authored by Daniel Einhorn
This map shows the geographic impact of Daniel Einhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Einhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Einhorn more than expected).
Fields of papers citing papers by Daniel Einhorn
This network shows the impact of papers produced by Daniel Einhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Einhorn. The network helps show where Daniel Einhorn may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Einhorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control Hit paper breakdown → | 2009 | 1016 |
| 2 | American College of Endocrinology Position Statement on the Insulin Resistance Syndrome Hit paper breakdown → | 2003 | 813 |
| 3 | Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control Hit paper breakdown → | 2009 | 767 |
| 4 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary Hit paper breakdown → | 2020 | 431 |
| 5 | AACE/ADA Consensus Statement Hit paper breakdown → | 2009 | 416 |
| 6 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary Hit paper breakdown → | 2018 | 386 |
| 7 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary Hit paper breakdown → | 2017 | 338 |
| 8 | 2013 | 327 | |
| 9 | 2000 | 311 | |
| 10 | 2016 | 269 | |
| 11 | 2000 | 250 | |
| 12 | 2013 | 248 | |
| 13 | 2019 | 233 | |
| 14 | 2007 | 188 | |
| 15 | 2015 | 187 | |
| 16 | 2008 | 185 | |
| 17 | 2014 | 183 | |
| 18 | 2013 | 177 | |
| 19 | 2002 | 163 | |
| 20 | 2020 | 162 |
About Daniel Einhorn
Daniel Einhorn is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and Genetics, having authored 43 papers that have together received 7.7k indexed citations. Recurring topics across this work include Diabetes Management and Research (28 papers), Diabetes Treatment and Management (20 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (9 papers), Metabolism, Diabetes, and Cancer (7 papers), Pharmacology and Obesity Treatment (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Diabetes and associated disorders (5 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.0k citations), Pharmacology (565 citations), Physiology (782 citations), Surgery (1.2k citations) and Cardiology and Cardiovascular Medicine (473 citations). Daniel Einhorn has collaborated with scholars based in United States, Australia and Czechia. Frequent co-authors include Guillermo E. Umpierrez, George Grunberger, Irl B. Hirsch, Yehuda Handelsman, Alan J. Garber, Zachary T. Bloomgarden, Etie S. Moghissi, Paul S. Jellinger, Janet B. McGill and Silvio E. Inzucchi. Their work appears in journals such as Endocrine Practice, Diabetes Care, Diabetes Technology & Therapeutics, Clinical Therapeutics and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.